GlassScriptPhysician profile
Thomas L Tanous
NPI 1205030897
$697,979.93
in general payments reported to CMS, 2019-2025
15 companies · $134K in 2025
The $134K reported for 2025 was more than what 97% of Orthopaedic Surgery providers received nationally (typical 2025 total: $569).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $6,357 · 2020: $55K · 2021: $85K · 2022: $166K · 2023: $139K · 2024: $113K · 2025: $134K.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Education: $209K · Consulting Fee: $136K · Travel and Lodging: $33K · Food and Beverage: $8,776.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Education | $209,220.74 |
| Consulting Fee | $136,130.00 |
| Travel and Lodging | $32,548.87 |
| Food and Beverage | $8,775.86 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Zimmer Biomet Holdings, INC. | $696,458.57 | 2019-2025 | Rosa, Avenir, G7 |
| Sanara Medtech INC. | $454.07 | 2021-2023 | Celleraterx |
| Ethicon US, LLC | $287.88 | 2019-2025 | Stratafix |
| Horizon Therapeutics Plc | $274.76 | 2019-2021 | |
| Stryker Corporation | $131.14 | 2019 | |
| Smith+Nephew, INC. | $89.69 | 2022-2025 | Pico 7 |
| Depuy Synthes Sales INC. | $71.98 | 2019-2020 | |
| Aroa Biosurgery Incorporated | $41.12 | 2025 | |
| Pacira Therapeutics, INC. | $39.96 | 2019-2020 | |
| Medacta USA, INC. | $30.66 | 2022 | |
| Bone Support INC. | $23.70 | 2024 | Ceramentbone Void Filler, Cerament G |
| Breg, INC | $23.24 | 2025 | |
| Wright Medical Technology, INC. | $21.06 | 2019 | |
| Omnilife Science, INC | $20.86 | 2024 | Various Products |
| Vertical Pharmaceuticals, LLC | $11.24 | 2019 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Thomas Tanous listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.